Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Open Forum Infectious Diseases, 2023
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus

Schnittman S., Kolossváry M., Beck-Engeser G. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma

Clinical and Experimental Dermatology, 2023
HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp

Zhang Y., Grice S., Wang N. et al.

Olink Target 96Dermatological DiseasesPathophysiologyCell Culture Supernatant

Alimentary Pharmacology & Therapeutics, 2023
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease

Ungaro R., Hu L., Ji J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Nature Communications, 2023
Interpreting biologically informed neural networks for enhanced proteomic biomarker discovery and pathway analysis

Hartman E., Scott A., Karlsson C. et al.

Olink Target 96Wider Proteomics StudiesData ScienceUrine

Journal of the American Heart Association, 2023
Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study

Xu Q., Sun L., Wang Y. et al.

Olink Target 96CVDPathophysiologyPlasma

Cell Reports Medicine, 2023
Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses

Yuan S., Xu F., Li X. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Science Translational Medicine, 2023
A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Van Damme K., Hoste L., Declercq J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologySerum

Journal for ImmunoTherapy of Cancer, 2023
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Anker J., Pal S., Kim-Schulze S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Liver International, 2023
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers

Stankevic E., Israelsen M., Juel H. et al.

Olink Target 96HepatologyPathophysiologyPlasma

Journal of Endocrinological Investigation, 2023
Serum biomarkers related to frailty predict negative outcomes in older adults with hip fracture

Cedeno-Veloz B., Lozano-Vicario L., Rodríguez-García A. et al.

Olink Target 48AgingPatient StratificationSerum

Journal of Cancer Research and Clinical Oncology, 2023
Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study

Pham T., Nimptsch K., Papadimitriou N. et al.

Olink Target 96OncologyPathophysiologyPlasma

Antioxidants, 2023
Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents

Ullah A., Stankevic E., Holm L. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Journal of Cerebral Blood Flow & Metabolism, 2023
A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease

Overmars L., Kuipers S., van Es B. et al.

Olink Target 96CVDPathophysiologyPlasma

iScience, 2023
Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19

Shivram H., Hackney J., Rosenberger C. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologySerumBlood

Nature Immunology, 2023
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

Zhao J., Stacey D., Eriksson N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

eClinicalMedicine, 2023
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study

Zinzani P., Trněný M., Ribrag V. et al.

Olink Target 96OncologyPathophysiologyPlasma

Nature Genetics, 2023
Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis

Zhou S., Sosina O., Bovijn J. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Environmental Science & Technology, 2023
Effects of Short- And Medium-Term Exposures to Lower Air Temperature on 71 Novel Biomarkers of Subclinical Inflammation: Results from the KORA F4 Study

Ni W., Breitner S., Nikolaou N. et al.

Olink Target 96Environmental Health & ToxicologyPathophysiologySerum

Allergy, 2023
Dupilumab‐induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis

Ryser F., Yalamanoglu A., Valaperti A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Clinica Chimica Acta, 2023
Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform

Liu J., Chen B., Lu H. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

2996 publications